Long-acting β-agonists and exercise

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 2, 2008, Pages 251-253

  Weinberger, Miles ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

2 receptor downregulation; asthma; exercise induced dyspnea; Inhaled bronchodilators; long acting 2 agonists; tolerance

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; PIRBUTEROL; PIRBUTEROL ACETATE; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; TERBUTALINE; THEOPHYLLINE;

AIRWAY OBSTRUCTION; BRONCHODILATATION; BRONCHOSPASM; CONVALESCENCE; DYSPNEA; EDITORIAL; EXERCISE; EXERCISE INDUCED ASTHMA; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MORNING DOSAGE; PRIORITY JOURNAL; PROTECTION;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ASTHMA, EXERCISE-INDUCED; BRONCHODILATOR AGENTS; ETHANOLAMINES; EXERCISE; HUMANS; SPORTS;

EID: 48349092988     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.05.030     Document Type: Editorial

References (15)

1. Solis-Cohen S. The use of adrenal substance in the treatment of asthma. JAMA 34 (1900) 1164
2. LaForce C., Alexander M., Deckelmann R., Fabbri L.M., Aisanov Z., Cameron R., et al. Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study. Allergy 63 (2008) 103-111
3. Greening A.P., Ind P., Northfield M., and Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid (Allen & Hanburys Limited UK Study Group). Lancet 344 (1994) 219-224
4. Woolcock A., Lundback B., Ringdal N., and Jacques L.A. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroid. Am J Respir Crit Care Med 153 (1996) 1481-1488
5. Nelson H.S., Weiss S.T., Bleecker E.R., Yancey S.W., Dorinsky P., and SMART Study Group. The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129 (2006) 15-26
6. Aaronson D.W. The "black box" warning and allergy drugs. J Allergy Clin Immunol 117 (2006) 40-44
7. Abu-Hasan M., Tannous B., and Weinberger M. Exercise-induced dyspnea in children and adolescents: if not asthma then what?. Ann Allergy Asthma Immunol 94 (2005) 366-371
8. Shapiro G.S., Yegen U., Xiang J., Kottakis J., and Cioppa G.D. A randomized, double-blind, single dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol. Clin Ther 24 (2002) 2077-2087
9. Nelson J.A., Strauss L., Skowronski M., Ciufo R., Novak R., and McFadden E.R. Effect of long-term salmeterol treatment on exercise-induced asthma. N Eng J Med 339 (1998) 141-146
10. Simons F.E., Gerstner T.V., and Cheang M.S. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics 99 (1997) 655-659
11. 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future. Pediatr Drugs 6 (2004) 161-175
12. Taylor D.R. β-adrenergic receptor polymorphisms: relationship to the β-agonist controversy and clinical implications. Expert Opin Pharmacother 8 (2007) 3195-3203
13. 2 agonists. Lancet 370 (2007) 2075-2076
14. Weinberger M., and Abu-Hasan M. Life threatening asthma during treatment with salmeterol. N Engl J Med 335 (2006) 852-853
15. 2 agonists have an ergogenic potential in non-asthmatic competitive athletes?. Sports Med 37 (2007) 95-102